Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Articles

Page Path
HOME > Intest Res > Volume 8(2); 2010 > Article
Case Report A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient
Keun Young Shin, Jun Heo, Min Kyu Jung, Seong Woo Jeon, Sung Kook Kim
Intestinal Research 2010;8(2):177-180.
DOI: https://doi.org/10.5217/ir.2010.8.2.177
Published online: December 30, 2010
Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea
prev next
  • 2,625 Views
  • 18 Download
  • 0 Crossref
  • 0 Scopus
prev next

Crohn's disease (CD) is a chronic immune-mediated inflammatory disorder. Treatment strategies for CD are targeted toward various components of the proinflammatory mediators and subsequent immune response. Recently, the anti-tumor necrosis factor (TNF) monoclonal antibody, infliximab has been used in patients with CD. However, uncommon and unusual infections have been reported during anti-TNF-Ձ therapy and immunomodulator. Here, we report a case of pityriasis versicolor occurring in a patient with CD receiving infliximab treatment. The patient was successfully treated with topical ketoconazole. (Intest Res 2010;8:177-180)


Intest Res : Intestinal Research
Close layer
TOP